PMID- 28446809
OWN - NLM
STAT- MEDLINE
DCOM- 20180521
LR  - 20181113
IS  - 1348-4214 (Electronic)
IS  - 0916-9636 (Linking)
VI  - 40
IP  - 8
DP  - 2017 Aug
TI  - Blood pressure management in patients with type 2 diabetes mellitus.
PG  - 721-729
LID - 10.1038/hr.2017.55 [doi]
AB  - Hypertension aggravates macrovascular and microvascular diseases and mortality in 
      patients with type 2 diabetes mellitus (T2DM). The current Japanese Society of 
      Hypertension Guidelines of the Management of Hypertension (JSH 2014) recommends 
      that antihypertensive medication should be initiated concomitantly with lifestyle 
      modification when blood pressure (BP) is ⩾130/80 mm Hg and that target levels of 
      office and home BP should be <130/80 mm Hg and <125/75 mm Hg, respectively, in 
      T2DM patients. Considering more favorable metabolic profiles and renoprotective 
      effects than other classes of antihypertensive agents, angiotensin-converting 
      enzyme inhibitors and angiotensin II receptor blockers are recommended as the 
      first-line therapy for patients with hypertension and T2DM in JSH 2014. However, 
      the target BP and the first-line therapy remain controversial because of the 
      paucity of high-quality evidence with consistency. It is suggested that BP 
      management should be tailored for each patient with T2DM, based on tolerability 
      and considerations of comorbidity.
FAU - Kai, Hisashi
AU  - Kai H
AD  - Department of Cardiology, Kurume University Medical Center, Kurume, Japan.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170427
PL  - England
TA  - Hypertens Res
JT  - Hypertension research : official journal of the Japanese Society of Hypertension
JID - 9307690
RN  - 0 (Antihypertensive Agents)
SB  - IM
MH  - Antihypertensive Agents/*therapeutic use
MH  - *Blood Pressure
MH  - Diabetes Mellitus, Type 2/*complications/physiopathology
MH  - Humans
MH  - Hypertension/*drug therapy/etiology/physiopathology
MH  - Life Style
MH  - Treatment Outcome
EDAT- 2017/04/28 06:00
MHDA- 2018/05/22 06:00
CRDT- 2017/04/28 06:00
PHST- 2017/03/13 00:00 [received]
PHST- 2017/03/20 00:00 [revised]
PHST- 2017/03/21 00:00 [accepted]
PHST- 2017/04/28 06:00 [pubmed]
PHST- 2018/05/22 06:00 [medline]
PHST- 2017/04/28 06:00 [entrez]
AID - hr201755 [pii]
AID - 10.1038/hr.2017.55 [doi]
PST - ppublish
SO  - Hypertens Res. 2017 Aug;40(8):721-729. doi: 10.1038/hr.2017.55. Epub 2017 Apr 27.